Polyneuropathy in diabetic and nondiabetic patients on CAPD: Is there an association with HRQOL?

Peritoneal Dialysis International

Volumn 29, Issue 1, 2009, Pages 102-107

  Jovanovic, Dijana B ^a,b   Matanovic, Dragana D ^a   Simic Ogrizovic, Sanja P ^a   Stosovic, Milan D ^a   Bontic, Ana C ^a   Nesic, Vidosava D ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b NONE   (Serbia)

Author keywords

Diabetic patients; Dialysis adequacy; KDQOL; Polyneuropathy

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD CHEMISTRY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE DURATION; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MOTOR PERFORMANCE; NERVE CONDUCTION; NONDIABETIC PATIENT; PATIENT; PERONEUS NERVE; POLYNEUROPATHY; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SURAL NERVE; TIBIAL NERVE; TREATMENT DURATION; COMPARATIVE STUDY; FEMALE; FOLLOW UP; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PHYSIOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; PATIENT SATISFACTION; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERONEAL NERVE; POLYNEUROPATHIES; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SURAL NERVE; TIBIAL NERVE; UREMIA;

EID: 65349185046     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900114     Document Type: Article

References (27)

1. Asbury AK, Victor M, Adams RD. Uremic polyneuropathy. Arch Neurol 1963; 8:413-28.
2. Thomas PK. Screening for peripheral neuropathy in patients treated by chronic hemodialysis. Muscle Nerve 1978; 1:396-9.
3. Bolton CF. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 1980; 7:89-96.
4. Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, et al. Intravenous methylcobatamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 1999; 38:472-5.
5. Apostolou T, Gokal R. Neuropathy and quality of life in diabetic continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19(Suppl 2):S242-7.
6. Hassan K, Simri W, Rubenchik I, Manelis J, Gross B, Sasha MS, et al. Effects of erythropoietin therapy on polyneuropathy in predialytic patients. J Nephrol 2003; 16:121-5.
7. Bakewell BA, Higgins MR, Edmunds EM. Quality of life in peritoneal dialysis patients: decline over time and association with clinical outcomes. Kidney Int 2002; 61: 239-48.
8. Paniagua R, Amato D, Vonesh E, Guo A, Mujais S, for the Mexican Nephrology Collaborative Study Group. Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX Trial. Kidney Int 2005; 67:1093-104.
9. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, et al. Physiological factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998; 54:245-54.
10. Valderrabano F, Jofre R, Lopez-Gomez JM. Quality of life in end-stage renal disease patients. Am J Kidney Dis 2001; 38:443-64.
11. Fukuhara S, Lopez AA, Bragg-Gresham LJ, Kurokawa K, Mapes LD, Akizawa T, et al., for the Worldwide DOPPS. Health-related quality of life among dialysis patients on three continents: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 64:1903-10.
12. Keshaviah P. Adequacy of peritoneal dialysis. In: Gókal R, Nolph KD, eds. The Textbook of Peritoneal Dialysis. Dordrecht, The Netherlands: Kluwer Academic; 1994: 419-42.
13. Hays RD, Kallich JD, Mapes DL, Coons SJ, Amin N, Carter WB. Kidney Disease Quality of Life-Short Form (KDQOL-SF™) Version 1.1: A Manual for Use and Scoring. Santa Monica, CA: RAND; 1995: 7928.
14. Laaksonen S, Metsarinne K, Voipio-Pukki LM, Falck B. Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve 2002; 25:884-90.
15. Bolton CF. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci 1980; 7:89-96.
16. Makkar RK, Kochar DK. Somatosensory evoked potentials (SSEPs), sensory nerve conduction velocity (SNCV) and motor nerve conduction velocity (MNCV) in chronic renal failure. Electromyogr Clin Neurophysiol 1994; 34:295-300.
17. Bazzi C, Pagani C, Sorgato G, Albonico G, Fellin G, D'Amico G. Uremic polyneuropathy: a clinical and electrophysiological study in 135 short- and long-term hemodialyzed patients. Clin Nephrol 1991; 35:176-81.
18. Robson JS. Uremic neuropathy. In: Robertson RF, ed. Some Aspects of Neurology. Edinburgh: Royal College of Physicians; 1968: 74-84.
19. Bolton CF. Peripheral neuropathy associated with chronic renal failure. Can J Neurol Sci 1980; 7:89.
20. Bolton CF, Young GB. Uremic neuropathy. In: Neurological Complications of Renal Disease. Boston: Butterworth; 1990: 76-207.
21. Neundorfer B. Polyneuropathies - symptoms, causes and diagnostic procedure [in German]. Ther Umsch 1993; 50: 761-5.
22. Vinik AI, Park TS, Stransberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000; 43:957-73.
23. Asbury AK. Neuropathies with renal failure, hepatic disorders, chronic respiratory insufficiency, and critical illness. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993: 1251-7.
24. Adams RD, Victor M. Disease of the peripheral nerves. In: Principles of Neurology. 5th ed. New York: McGraw-Hill; 1993: 1144-5.
25. Reichard P, Nilson BY, Rosenqvist U. The effect of long term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329:304-9.
26. Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabet Complications 2006; 20:216-23.
27. Fisher MA, Langbein WE, Collins EG, Williams K, Covine L. Physiological improvement with moderate exercise in type II diabetic neuropathy. Electromyogr Clin Neurophysiol 2007; 47:23-8.